BridgeMD
New treatment option for Healthy Infants
Official title HMOs on Infant Gut Microbiota Modulation and Development of the Immune System in Healthy Infants
ClinicalTrials.gov ID: NCT06631937
What this study is testing
- What it's testing
- The goal of this clinical trial is to learn how a mixture of human milk oligosaccharides impacts the development of the infant microbiota, the immune maturation and how the interaction between the microbiota and immune maturation may impact both short and long term health of the infant. The participants will: Consume the investigational products (active/placebo) for 6 months Legal guardians/parents to the participant to collect stool samples from the diapers at home Legal guardians/parents to the participant to report gastrointestinal symptoms, signs of infections in an electronic questionnaire Visit the clinic for checkups and dried blood sample collection For reference, a group of breastfed infants will be included.
- You might receive a placebo (an inactive treatment) instead of the study drug, decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 0 to 28. Healthy volunteers may be eligible.
You may be able to join if
- All infants which parents has decided mode of feeding
You likely can't join if
- Premature birth
The study team makes the final eligibility decision.
Where it's taking place
- Aarhus, Denmark
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 0 days to 28 days. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Aarhus, Denmark. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.